Government Pharmaceutical Technology 
Workplace Insight
NOVEMBER 26, 2023
The ongoing advancements in technology have made remote collaboration more feasible and seamless than ever before. Collaboration tools have become essential in ensuring the coexistence of the digital and physical workplace, both internally with employees and externally with clients.
Work Life
DECEMBER 14, 2023
But despite government incentives for green energy initiatives, financing that growth may be challenging amid high interest rates and material costs, which could lead to project delays. Pharmaceutical Pharmaceutical companies have had a difficult year: the industry is grappling with softening demand for COVID-19-related products.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Tanveer Naseer
MAY 16, 2011
Russell is an educational psychologist, author, executive coach and management consultant whose clients include Fortune 500 executives in aerospace, healthcare, pharmaceutical and biotechnology, information technology, telecommunications and oil and gas. When Fraud Prevention Becomes Cause Prevention.
Mad in America
DECEMBER 4, 2023
Blaming greedy lawyers for our healthcare cost problem comes under the same category as blaming modern medical advances, the expensive new technology and medicines to identify—and at times—cure diseases, and other common “red herrings” in the healthcare industry.
Mad in America
FEBRUARY 20, 2024
If only he could apply himself to his study of history and government he would be well qualified for the job (But who are we kidding? He rattles on about statistics, techniques, “behavioral interventions” and other technologies that show “statistically significant” effects in modifying student and adolescent behavior.
Mad in America
OCTOBER 21, 2023
In these interviews, I have talked about the components of the psychiatric-pharmaceutical-industrial complex, along with how psychiatry meets the political needs of the ruling class and dysfunctional families. Mainstream media is another major player in the psychiatric-pharmaceutical-industrial complex. Evolutionary geneticist R.C.
Mad in America
SEPTEMBER 20, 2024
Jon Jureidini was doing research into patient experiences of antidepressant withdrawal with a view to making submissions to government. In the prevailing Australian Government view, withdrawal symptoms affect a small minority and probably represents relapse to the original condition. I contacted him, and he graciously took me on.
Expert insights. Personalized for you.
116 
Let's personalize your content